Estimating the odds ratios of Crohn disease for the main CARD15/NOD2 mutations using a conditional maximum likelihood method in pedigrees collected via affected family members

European Journal of Human Genetics

Volumn 15, Issue 8, 2007, Pages 864-871

  Pascoe, Leigh ^a   Zouali, Habib ^a   Sahbatou, Mourad ^a   Hugot, Jean Pierre ^b  

^a FONDATION JEAN DAUSSET CEPH   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15;

ARTICLE; CONTROLLED STUDY; CROHN DISEASE; FAMILY; GENE FREQUENCY; GENE LOCUS; GENE MUTATION; GENETIC SUSCEPTIBILITY; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MAXIMUM LIKELIHOOD METHOD; PEDIGREE; PRIORITY JOURNAL; RISK ASSESSMENT;

AMINO ACID SUBSTITUTION; CROHN DISEASE; DATA INTERPRETATION, STATISTICAL; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LIKELIHOOD FUNCTIONS; NOD2 SIGNALING ADAPTOR PROTEIN; ODDS RATIO; PEDIGREE;

EID: 34547173613     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/sj.ejhg.5201839     Document Type: Article

References (15)

1. Hugot JP, Chamaillard M, Zouali H et al: Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001; 411: 599-603.
2. Ogura Y, Bonen DK, Inohara N et al: A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001; 411: 603-606.
3. Lesage S, Zouali H, Cezard JP et al: CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet 2002; 70: 845-857.
4. King K, Sheikh MF, Cuthbert AP et al: Mutation, selection, and evolution of the Crohn disease susceptibility gene CARD15. Hum Mutat 2006; 27: 44-54.
5. Vermeire S, Wild G, Kocher K et al: CARD15 genetic variation in a Quebec population: Prevalence, genotype-phenotype relationship, and haplotype structure. Am J Hum Genet 2002; 71: 74-83.
6. Hampe J, Cuthbert A, Croucher PJ et al: Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet 2001; 357: 1925-1928.
7. Economou M, Trikalinos TA, Loizou KT, Tsianos EV, Ioannidis JP: Differential effects of NOD2 variants on Crohn's disease risk and phenotype in diverse populations: A metaanalysis. Am J Gastroenterol 2004; 99: 2393-2404.
8. Lennard-Jones JE: Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl 1989; 170: 2-6 (Discussion 16-19).
9. Hugot JP: Role of NOD2 gene in Crohn's disease. Gastroenterol Clin Biol 2002; 26: 13-15
10. Girardin SE, Hugot JPT Sansonetti PJ: Lessons from Nod2 studies: towards a link between Crohn's disease and bacterial sensing. Trends Immunol 2003; 24: 652-658.
11. Barnich N, Aguirre JE, Reinecker HC, Xavier R, Podolsky DK: Membrane recruitment of NOD2 in intestinal epithelial cells is essential for nuclear fac. J Cell Biol 2005; 170: 21-26.
12. Chamaillard M, Philpott D, Girardin SE et al: Gene-environment interaction modulated by allelic heterogeneity in inflammatory diseases. Proc Natl Acad Sci USA 2003; 100: 3455-3460.
13. Spielman RS, McGinnis RE, Ewens WJ: Transmission test for linkage disequilibrium: The insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 1993; 52: 506-516.
14. Schaid DJ, Sommer SM: Genotype relative risks: methods for design and analysis of candidate-gene association studies. Am J Hum Genet 1993; 53: 1114-1126.
15. Falk CT, Rubinstein A: Haplotype relative risks: an easy reliable way to construct a proper control sample for risk calculations. Ann Hum Genet 1987; 51 (Part 3): 227-233.